Antigen presentation of the immunodominant T-cell epitope of the major mugwort pollen allergen, Art v 1, is associated with the expression of HLA-DRB1*01

Journal of Allergy and Clinical Immunology

Volumn 115, Issue 2, 2005, Pages 399-404

  Jahn Schmid, Beatrice ^a   Fischer, Gottfried F ^a   Bohle, Barbara ^a   Faé, Ingrid ^a   Gadermaier, Gabriele ^b   Dedic, Azra ^b   Ferreira, Fatima ^b   Ebner, Christof ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b UNIVERSITY OF SALZBURG   (Austria)

Author keywords

Art v 1; HLA association; HLA DRB1*01; Mugwort pollinosis; Peptide immunotherapy; Type I allergy

Indexed keywords

AMINO ACID; ART V 1 ALLERGEN; EPITOPE; HLA ANTIBODY; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; MONOCLONAL ANTIBODY; OLIGONUCLEOTIDE; POLLEN ANTIGEN; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; ALLELE; ANTIBODY SPECIFICITY; ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; BINDING SITE; CELL HYBRIDIZATION; CELL LINE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; HLA TYPING; HUMAN; HUMAN CELL; IMMUNOREACTIVITY; IMMUNOTHERAPY; MALE; MOLECULAR CLONING; MOLECULAR RECOGNITION; NUCLEOTIDE SEQUENCE; PHENOTYPE; POLLEN ALLERGY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBSTITUTION REACTION; T LYMPHOCYTE;

EID: 13444310921     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaci.2004.10.010     Document Type: Article

References (34)

1. F.T. Spieksma, H. Charpin, N. Nolard, and E. Stix City spore concentrations in the European Economic Community (EEC). IV. Summer weed pollen (Rumex, Plantago, Chenopodiaceae, Artemisia), 1976 and 1977 Clin Allergy 10 1980 319 329
2. F.G. Futin, K. Person, and W. Gutermann Artemisia 1976 University Press Cambridge
3. B. Wuthrich, J. Stager, and S.G. Johansson Celery allergy associated with birch and mugwort pollinosis Allergy 45 1990 566 571
4. L. Bauer, C. Ebner, R. Hirschwehr, B. Wuthrich, C. Pichler, and R. Fritsch IgE cross-reactivity between birch pollen, mugwort pollen and celery is due to at least three distinct cross-reacting allergens: immunoblot investigation of the birch-mugwort-celery syndrome Clin Exp Allergy 26 1996 1161 1170
5. H. Breiteneder, K. Hoffmann-Sommergruber, G. O'Riordain, M. Susani, H. Ahorn, and C. Ebner Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17-kDa tree pollen allergens Eur J Biochem 233 1995 484 489
6. D. Luttkopf, B.K. Ballmer-Weber, B. Wuthrich, and S. Vieths Celery allergens in patients with positive double-blind placebo-controlled food challenge J Allergy Clin Immunol 106 2000 390 399
7. R. Hirschwehr, C. Heppner, S. Spitzauer, W.R. Sperr, P. Valent, and U. Berger Identification of common allergenic structures in mugwort and ragweed pollen J Allergy Clin Immunol 101 1998 196 206
8. N. Wopfner, M. Willeroidee, D. Hebenstreit, R. van Ree, M. Aalbers, and P. Briza Molecular and immunological characterization of profilin from mugwort pollen Biol Chem 383 2002 1779 1789
9. M. Himly, B. Jahn-Schmid, A. Dedic, P. Kelemen, N. Wopfner, and F. Altmann Art v 1, the major allergen of mugwort pollen, is a modular glycoprotein with a defensin-like and a hydroxyproline-rich domain FASEB J 17 2003 106 108
10. P. Schmid-Grendelmeier, D. Holzmann, M. Himly, M. Weichel, S. Tresch, and B. Ruckert Native Art v 1 and recombinant Art v 1 are able to induce humoral and T cell-mediated in vitro and in vivo responses in mugwort allergy J Allergy Clin Immunol 111 2003 1328 1336
11. B. Jahn-Schmid, P. Kelemen, M. Himly, B. Bohle, G. Fischer, and F. Ferreira The T cell response to Art v 1, the major mugwort pollen allergen, is dominated by one epitope J Immunol 169 2002 6005 6011
12. S. Romagnani The role of lymphocytes in allergic disease J Allergy Clin Immunol 105 2000 399 408
13. R.J. van Neerven, C. Ebner, H. Yssel, M.L. Kapsenberg, and J.R. Lamb T-cell responses to allergens: epitope-specificity and clinical relevance Immunol Today 17 1996 526 532
14. J. Bousquet, R. Lockey, and H.J. Malling Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper J Allergy Clin Immunol 102 1998 558 562
15. M. Larche, F. Ferreira, and S.S. Mohapatra Modifying allergens and using adjuvants for specific immunotherapy Clin Allergy Immunol 18 2004 641 661
16. P.S. Norman, J.L. Ohman Jr., A.A. Long, P.S. Creticos, M.A. Gefter, and Z. Shaked Treatment of cat allergy with T-cell reactive peptides Am J Respir Crit Care Med 154 1996 1623 1628
17. J. Pene, A. Desroches, L. Paradis, B. Lebel, M. Farce, and C.F. Nicodemus Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats J Allergy Clin Immunol 102 1998 571 578
18. F.E. Simons, M. Imada, Y. Li, W.T. Watson, and K.T. HayGlass Fel d 1 peptides: effect on skin tests and cytokine synthesis in cat-allergic human subjects Int Immunol 8 1996 1937 1945
19. P. Maguire, C. Nicodemus, D. Robinson, D. Aaronson, and D.T. Umetsu The safety and efficacy of ALLERVAX CAT in cat allergic patients Clin Immunol 93 1999 222 231
20. W.L. Oldfield, A.B. Kay, and M. Larche Allergen-derived T cell peptide-induced late asthmatic reactions precede the induction of antigen-specific hyporesponsiveness in atopic allergic asthmatic subjects J Immunol 167 2001 1734 1739
21. U. Muller, C.A. Akdis, M. Fricker, M. Akdis, T. Blesken, and F. Bettens Successful immunotherapy with T-cell epitope peptides of bee venom phospholipase A2 induces specific T-cell anergy in patients allergic to bee venom J Allergy Clin Immunol 101 1998 747 754
22. J.M. Fellrath, A. Kettner, N. Dufour, C. Frigerio, D. Schneeberger, and A. Leimgruber Allergen-specific T-cell tolerance induction with allergen-derived long synthetic peptides: results of a phase I trial J Allergy Clin Immunol 111 2003 854 861
23. B.M. Haselden, A.B. Kay, and M. Larche Peptide-mediated immune responses in specific immunotherapy Int Arch Allergy Immunol 122 2000 229 237
24. A. Barry Kay, and M. Larche Allergen immunotherapy with cat allergen peptides Springer Semin Immunopathol 25 2004 391 399
25. G. Fischer Caucasian Austrian normal P.I. Terasaki D.W. Gjertson HLA 1997 1997 UCLA Tissue Typing Laboratory Los Angeles 194
26. S.K. Huang, M. Yi, E. Palmer, and D.G. Marsh A dominant T cell receptor beta-chain in response to a short ragweed allergen, Amb a 5 J Immunol 154 1995 6157 6162
27. R.P. Young, J.W. Dekker, B.P. Wordsworth, C. Schou, K.D. Pile, and F. Matthiesen HLA-DR and HLA-DP genotypes and immunoglobulin E responses to common major allergens Clin Exp Allergy 24 1994 431 439
28. J.A. Faux, M.F. Moffatt, A. Lalvani, J. Dekker, D.A. Warrell, and W.O. Cookson Sensitivity to bee and wasp venoms: association with specific IgE responses to the bee and wasp venom and HLA DRB1 and DPB1 Clin Exp Allergy 27 1997 578 583
29. S.K. Huang, P. Zwollo, and D.G. Marsh Class II major histocompatibility complex restriction of human T cell responses to short ragweed allergen, Amb a V Eur J Immunol 21 1991 1469 1473
30. D. O'Sullivan, T. Arrhenius, J. Sidney, M.F. Del Guercio, M. Albertson, and M. Wall On the interaction of promiscuous antigenic peptides with different DR alleles. Identification of common structural motifs J Immunol 147 1991 2663 2669
31. *0401 J Immunol 152 1994 2890 2898
32. S. Southwood, J. Sidney, A. Kondo, M.F. del Guercio, E. Appella, and S. Hoffman Several common HLA-DR types share largely overlapping peptide binding repertoires J Immunol 160 1998 3363 3373
33. C. Texier, S. Pouvelle, M. Busson, M. Herve, D. Charron, and A. Menez HLA-DR restricted peptide candidates for bee venom immunotherapy J Immunol 164 2000 3177 3184
34. T.S. Jardetzky, J.C. Gorga, R. Busch, J. Rothbard, J.L. Strominger, and D.C. Wiley Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding EMBO J 9 1990 1797 1803